WallStreetZen

NYSE: JNJ
Johnson & Johnson Earnings & Revenue

JNJ past earnings growth

How has JNJ's earnings growth performed historically?
Company
21.43%
Industry
12.52%
Market
38.18%
JNJ's earnings have grown slower (4.04% per year) than the US Drug Manufacturers - General industry average (6.08%)
Performance
JNJ's earnings have grown slower (4.04% per year) than the US market average (28.61%)
Performance
JNJ's earnings growth is accelerating - its growth over the last year (21.43%) is above its 5-year compound annual rate (4.04%)
Performance

JNJ past revenue growth

How has JNJ's revenue growth performed historically?
Company
-1.04%
Industry
8.9%
Market
16%
JNJ's revenue has grown slower (2.77% per year) than the US Drug Manufacturers - General industry average (4.25%)
Performance
JNJ's revenue has grown slower (2.77% per year) than the US market average (16.19%)
Performance
JNJ's revenue growth is slowing down - its growth over the last year (-1.04%) is below its 5-year compound annual rate (2.77%)
Performance

JNJ earnings and revenue history

Current Revenue
$80.9B
Current Earnings
$17.0B
Current Profit Margin
21%
JNJ's has not demonstrated consistent long-term earnings growth over the past 10 years (30.77%)
Performance

JNJ Return on equity

Current Company
27.4%
Current Industry
55.3%
Current Market
23.9%
JNJ's Return on Equity (27.4%) shows a company that is highly efficient at transforming shareholder equity into returns
Performance

JNJ Return on assets

Current Company
10.6%
Current Industry
8.6%
Current Market
6.2%
JNJ is generating higher Return on Assets (10.6%) than the US Drug Manufacturers - General industry average (8.23%)
Performance

JNJ Return on capital employed

Current Company
14.61%
Current Industry
12.8%
JNJ's ability to generate Return on Capital (14.61%) has decreased compared to 3 years ago (16.38%)
Performance

JNJ earnings dates

Next earnings date
Jan 26, 2021

Johnson & Johnson Earnings & Revenue FAQ

What were JNJ's earnings last quarter?

On Oct 13, 2020, Johnson & Johnson (NYSE: JNJ) reported Q3 2020 earnings per share (EPS) of $1.35, up 101.49% year over year. Total Johnson & Johnson earnings for the quarter were $3.55 billion. In the same quarter last year, Johnson & Johnson's earnings per share (EPS) was $0.67.

What was JNJ's revenue last quarter?

On Oct 13, 2020, Johnson & Johnson (NYSE: JNJ) reported Q3 2020 revenue of $21.08 billion up 1.7% year over year. In the same quarter last year, Johnson & Johnson's revenue was $20.73 billion.

What was JNJ's earnings growth in the past year?

As of Q1 2021, Johnson & Johnson's earnings has grown 21.43% year over year. This is 8.91 percentage points higher than the US Drug Manufacturers - General industry earnings growth rate of 12.52%. Johnson & Johnson's earnings in the past year totalled $16.99 billion.

What was JNJ's revenue growth in the past year?

As of Q1 2021, Johnson & Johnson's revenue has grown -1.04% year over year. This is 9.94 percentage points lower than the US Drug Manufacturers - General industry revenue growth rate of 8.9%. Johnson & Johnson's revenue in the past year totalled $80.86 billion.

What is JNJ's earnings date?

Johnson & Johnson's earnings date is Jan 26, 2021. Add JNJ to your watchlist to be reminded of JNJ's next earnings announcement.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Heap | Mobile and Web Analytics